KELLEY HANAU: Open Payments
NPI 1225235898 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 106 payments from 19 companies in 2025. Trend: 2023 $2,502 · 2024 $1,781 · 2025 $1,654
Food & beverage: $1,654
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $336 |
| Otsuka America Pharmaceutical, Inc. | 17 | $262 |
| Lundbeck LLC | 19 | $194 |
| Janssen Pharmaceuticals, Inc | 4 | $105 |
| Axsome Therapeutics, Inc. | 6 | $101 |
| Supernus Pharmaceuticals, Inc. | 2 | $83 |
| E.R. Squibb & Sons, L.L.C. | 5 | $74 |
| Biogen, Inc. | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Corium, LLC | 2 | $53 |
Products named: REXULTI, VRAYLAR, Auvelity, SPRAVATO, Qelbree, COBENFY, ZURZUVAE, TRINTELLIX.
Industry payments across NE — which companies pay providers there.
